CN Patent
CN103058960B — 卡巴他赛多晶型形式及其制备方法
Assigned to Jiangsu Aosaikang Pharmaceutical Co Ltd · Expires 2014-12-10 · 11y expired
What this patent protects
本发明属于医药技术领域,涉及卡巴他赛多晶型形式及其制备方法,具体来说,提供了卡巴他赛的无水物、一水合物和二水合物的新晶型形式以及其制备方法。本发明提供的新晶型,产品稳定性好、制备工艺简单,质量重现性良好,产品纯度易于控制,适合工业化生产。
USPTO Abstract
本发明属于医药技术领域,涉及卡巴他赛多晶型形式及其制备方法,具体来说,提供了卡巴他赛的无水物、一水合物和二水合物的新晶型形式以及其制备方法。本发明提供的新晶型,产品稳定性好、制备工艺简单,质量重现性良好,产品纯度易于控制,适合工业化生产。
Drugs covered by this patent
- Jevtana Kit (cabazitaxel) · Accord Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.